annual shareholders equity:
$1.23B+$198.73M(+19.28%)Summary
- As of today (June 17, 2025), DNLI annual stockholders equity is $1.23 billion, with the most recent change of +$198.73 million (+19.28%) on December 31, 2024.
- During the last 3 years, DNLI annual shareholders equity has risen by +$267.39 million (+27.79%).
- DNLI annual shareholders equity is now at all-time high.
Performance
DNLI Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$1.12B-$107.00M(-8.70%)Summary
- As of today (June 17, 2025), DNLI quarterly stockholders equity is $1.12 billion, with the most recent change of -$107.00 million (-8.70%) on March 31, 2025.
- Over the past year, DNLI quarterly shareholders equity has dropped by -$332.79 million (-22.86%).
- DNLI quarterly shareholders equity is now -22.86% below its all-time high of $1.46 billion, reached on March 31, 2024.
Performance
DNLI quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
DNLI Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.3% | -22.9% |
| 3 y3 years | +27.8% | +22.3% |
| 5 y5 years | +211.4% | +105.9% |
DNLI Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.8% | -22.9% | +38.4% |
| 5 y | 5-year | at high | +211.4% | -22.9% | +123.6% |
| alltime | all time | at high | +1406.0% | -22.9% | +1292.4% |
DNLI Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.12B(-8.7%) |
| Dec 2024 | $1.23B(+19.3%) | $1.23B(-6.7%) |
| Sep 2024 | - | $1.32B(-4.9%) |
| Jun 2024 | - | $1.39B(-4.7%) |
| Mar 2024 | - | $1.46B(+41.2%) |
| Dec 2023 | $1.03B(-1.1%) | $1.03B(-7.8%) |
| Sep 2023 | - | $1.12B(-5.8%) |
| Jun 2023 | - | $1.19B(+22.8%) |
| Mar 2023 | - | $966.71M(-7.3%) |
| Dec 2022 | $1.04B(+8.3%) | $1.04B(+28.5%) |
| Sep 2022 | - | $811.30M(-8.3%) |
| Jun 2022 | - | $884.45M(-3.6%) |
| Mar 2022 | - | $917.93M(-4.6%) |
| Dec 2021 | $962.29M | $962.29M(-4.9%) |
| Sep 2021 | - | $1.01B(-5.6%) |
| Jun 2021 | - | $1.07B(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $1.11B(-3.9%) |
| Dec 2020 | $1.15B(+191.4%) | $1.15B(+30.4%) |
| Sep 2020 | - | $882.55M(+75.7%) |
| Jun 2020 | - | $502.17M(-7.9%) |
| Mar 2020 | - | $545.31M(+38.1%) |
| Dec 2019 | $394.89M(-27.8%) | $394.89M(-9.9%) |
| Sep 2019 | - | $438.20M(-7.8%) |
| Jun 2019 | - | $475.17M(-8.0%) |
| Mar 2019 | - | $516.65M(-5.5%) |
| Dec 2018 | $546.85M(+17.4%) | $546.85M(+18.6%) |
| Sep 2018 | - | $461.18M(-5.9%) |
| Jun 2018 | - | $490.27M(-9.0%) |
| Mar 2018 | - | $539.03M(+15.7%) |
| Dec 2017 | $465.80M(-594.7%) | $465.80M(+141.2%) |
| Sep 2017 | - | $193.14M(-305.1%) |
| Dec 2016 | -$94.15M(+502.2%) | -$94.15M |
| Dec 2015 | -$15.63M | - |
FAQ
- What is Denali Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Denali Therapeutics?
- What is Denali Therapeutics annual shareholders equity year-on-year change?
- What is Denali Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Denali Therapeutics?
- What is Denali Therapeutics quarterly shareholders equity year-on-year change?
What is Denali Therapeutics annual stockholders equity?
The current annual shareholders equity of DNLI is $1.23B
What is the all time high annual shareholders equity for Denali Therapeutics?
Denali Therapeutics all-time high annual stockholders equity is $1.23B
What is Denali Therapeutics annual shareholders equity year-on-year change?
Over the past year, DNLI annual stockholders equity has changed by +$198.73M (+19.28%)
What is Denali Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of DNLI is $1.12B
What is the all time high quarterly shareholders equity for Denali Therapeutics?
Denali Therapeutics all-time high quarterly stockholders equity is $1.46B
What is Denali Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, DNLI quarterly stockholders equity has changed by -$332.79M (-22.86%)